News

October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.

Home October 22, 2007
Home
News

October 23, 2007 - Toshiba America Medical Systems Inc. today announced that the first U.S. installation of the Infinix ...

Home October 22, 2007
Home
News

October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...

Home October 22, 2007
Home
News

OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...

Home October 22, 2007
Home
News

October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...

Home October 22, 2007
Home
News

October 22, 2007 – Philips highlighted the integration of Volcano’s IVUS into its new Xper system and TrueView’s ability ...

Home October 21, 2007
Home
News

October 22, 2007 - Implantation of the CYPHER Sirolimus-eluting Coronary Stent by Cordis Corp. used to treat completely ...

Home October 21, 2007
Home
News

October 22, 2007 - GE Healthcare highlighted the advantages of its digital flat panel Biplane imaging systems, the ...

Home October 21, 2007
Home
News

October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...

Home October 21, 2007
Home
Technology

The HI VISION 5500 fully digital ultrasound system reportedly delivers the latest generation of signal processing ...

Home October 18, 2007
Home
News

October 18, 2007 - Toshiba America Medical Systems Inc. is showcasing its suite of workflow and storage enhancements for ...

Home October 17, 2007
Home
News

October 18, 2007 - At TCT 2007, Philips Medical Systems is presenting two live interventional cases with the University ...

Home October 17, 2007
Home
News

October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis, reportedly reducing the need for stocking multiple hemostasis products.

Home October 17, 2007
Home
28475_3
Feature | Melissa Allen

During the last several decades, the prevalence of Methicillin-Resistant Staphylococus Aureus (MRSA) and other ...

Home October 17, 2007
Home
News

October 18, 2007 - Cordis Corp. will present clinical data backing the CYPHER Sirolimus-eluting coronary stent at the ...

Home October 17, 2007
Home
Subscribe Now